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Structure of the ERM Protein Moesin Reveals
the FERM Domain Fold Masked by an Extended
Actin Binding Tail Domain
surface structures (Berryman et al., 1993). Despite their
distinct names, their functional similarities are such that
the ERM proteins can be considered as isoforms of a
single key protein. Indeed, Drosophila and C. elegans
each have only one type of ERM protein. The absolute
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requirement for at least one ERM protein in the formation²Department of Biochemistry and Biophysics
of cell surface structures is best shown by antisenseOregon State University
experiments in cultured cells (Takeuchi et al., 1994). TheCorvallis, Oregon 97331
recent report that a moesin knockout mouse has no
phenotype (Doi et al., 1999) is consistent with the func-
tional similarities of ERM proteins, in that the remainingSummary
ezrin and radixin could substitute for moesin.
The ERM proteins are different from most FERM con-The ezrin-radixin-moesin (ERM) protein family link ac-
taining proteins in that, as shown in Figure 1B, theirtin filaments of cell surface structures to the plasma
activity is regulated by intramolecular masking of pro-membrane, using a C-terminal F-actin binding seg-
tein±protein interaction sites (reviewed in Bretscher,ment and an N-terminal FERM domain, a common
1999). Such conformational regulation is poorly under-membrane binding module. ERM proteins are regu-
stood but may have wide generality as it has been pro-lated by an intramolecular association of the FERM
posed for several proteins, with another cytoskeletaland C-terminal tail domains that masks their binding
example being vinculin (Johnson and Craig, 1994, 1995;sites. The crystal structure of a dormant moesin
Bakolista et al., 1999). For ERM proteins, the polypeptideFERM/tail complex reveals that the FERM domain has
can be divided into three regions: an z300 residue N-ter-three compact lobes including an integrated PTB/PH/
minal FERM domain, an z200 residue central a domainEVH1 fold, with the C-terminal segment bound as an
that has a heptad hydrophobicity pattern characteristicextended peptide masking a large surface of the FERM
of coiled±coil proteins, and an z100 residue C-terminaldomain. This extended binding mode suggests a novel
tail domain. ERM proteins are isolated as monomersmechanism for how different signals could produce
and homo- or heterodimers in which the FERM domainvarying levels of activation. Sequence conservation
is bound tightly to the tail domain (Gary and Bretscher,
suggests a similar regulation of the tumor suppressor
1995) (Figure 1). Such molecules are dormant, because
merlin.
the FERM/tail interaction mutually masks the binding
sites for other molecules (Gary and Bretscher, 1995;
Introduction Takahashi et al., 1997; Reczek and Bretscher, 1998).
For cytoskeleton±membrane crosslinking, the dormant
FERM domains (band four-point-one, ezrin, radixin, molecule becomes activated and the FERM domain at-
moesin homology domains) are widespread protein taches to the membrane by binding specific membrane
modules of z300 amino acids in length that are involved proteins (see Figure 1B legend), while the last 34 resi-
in localizing proteins to the plasma membrane (Chisti dues of the tail bind actin filaments (Turunen et al., 1994;
et al., 1998). The FERM domain defines members of Pestonjamasp et al., 1995). Two pathways are believed
the band 4.1 superfamily, which includes cytoskeletal to contribute in vivo and in vitro to activation: phosphor-
proteins such as erythrocyte band 4.1, talin, and the ylation of the tail at Thr558 (human moesin numbering
ezrin-radixin-moesin (ERM) protein family, as well as is used throughout) (Nakamura et al., 1995; Matsui et
several tyrosine kinases and phosphatases and the tu- al., 1998; Pietromonaco et al., 1998) and exposure to
mor suppressor protein, merlin (Figure 1A). The ERM polyphosphatidyl inositides (Niggli et al., 1995, Hirao et
proteins have been a subject of particular interest be- al., 1996; Huang et al., 1999; Matsui et al., 1999; Naka-
cause of their direct involvement in the dynamics of mura et al., 1999). Phosphorylation at Thr558 weakens
interaction between the plasma membrane and the actin the FERM/tail interaction (Matsui et al., 1998) and, in
cytoskeleton. Specifically, they function as conforma- the presence of phospholipids, unmasks the membrane
tionally regulated membrane±cytoskeletal crosslinkers protein and F-actin binding sites (Simons et al., 1998).
in actin-rich cell surface structures, especially microvilli, In addition, Thr558Asp mutants of moesin appear to be
microspikes, and membrane ruffles (Bretscher, 1999). at least partially activated (Oshiro et al., 1998; Huang et
Ezrin (Bretscher, 1983; Gould et al., 1986; Pakkanen al., 1999). Aside from binding to membranes, the acti-
and Vaheri, 1989), radixin (Tsukita et al., 1989; Funayama vated FERM domain of ERM proteins can also bind the
guanine nucleotide dissociation inhibitor of Rho GTPaseet al., 1991), and moesin (Lankes and Furthmayr, 1991)
(RhoGDI), which suggests that in addition to functioningare close homologs (z75% sequence identity) that are
as a crosslinker, ERM proteins may influence Rho signal-all localized near the plasma membrane in actin-rich cell
ing pathways (Takahashi et al., 1997).
Merlin, the product of the neurofibromatosis type 2³ To whom correspondence should be addressed (e-mail: apb5@
tumor suppressor gene (Gusella et al., 1999), is uniquecornell.edu [A. B.]; karplusp@ucs.orst.edu [P. A. K.]).
in that its FERM domain has a very high 60% identity§ Present address: Laboratory of Molecular Biology, NIDDK, Na-
tional Institutes of Health, Bethesda, MD 20892. with the ERM proteins. Merlin's function is still poorly
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Figure 1. Representative FERM Domain±
Containing Proteins and a Model for the Con-
formational Masking of ERM Proteins
(A) The proteins of the band 4.1 superfamily
contain FERM domains (cyan) in combination
with other types of domains, including PDZ,
tyrosine phosphatase, SH2-like, tyrosine ki-
nase, kinase-like, myosin head, and PH do-
mains (Girault et al., 1999). The ERM proteins,
and possibly merlin, have a C-terminal tail
domain (red) that can mask binding sites on
the FERM domain.
(B) The dormant ERM molecule (left) has bind-
ing sites masked by an intramolecular inter-
action. Due to this association, the FERM and
tail domains of ERMs have also been called
by the functionally descriptive names the N-
and C-terminal ERM-association domains
(N-ERMAD and C-ERMAD) (Gary and Bret-
scher, 1995). After activation (right), the pro-
tein is able to link actin filaments that become
bound to the tail (red) to membrane proteins
(integral or peripheral) that become bound
to the FERM domain (cyan). The role of the
putative coiled-coil domain (A) is unknown.
Activation by phosphorylation at Thr558 is
shown as the best characterized factor that
affects activation. Although multiple ERM
proteins may combine in series to form ex-
tended crosslinks, a single crosslinking mole-
cule is shown. Known membrane-associated
ligands for the ERM±FERM domains include
the integral membrane proteins CD44, CD43
(Tsukita et al., 1994; Yonemura et al., 1998),
and intercellular adhesion molecules (Hel-
ander et al., 1996; Serrador et al., 1997;
Heiska et al., 1998), and the peripheral mem-
brane proteins ERM-binding phosphoprotein
50 (EBP50) (Reczek et al., 1997) and ex-
changer 3 kinase A regulatory protein
(E3KARP) (Reczek and Bretscher, 1998; Yun
et al., 1998). The central a domain can bind
the regulatory subunit of cAMP-dependent
protein kinase, and help localize this kinase
to the plasma membrane (Dransfield et al.,
1997).
understood, but it is clearly distinct from ERM proteins, prototype for all FERM domains, advancing studies of
this large family of membrane-associated proteins.as its function cannot be substituted by ERM proteins,
and it does not have a C-terminal actin binding site
(Huang et al., 1998). Although a functionally important Results and Discussion
head-to-tail interaction similar to that of the ERM family
members has been identified in merlin isoform I (Sher- Overall Structure
Attempts to crystallize full-length dormant ezrin or moe-man et al., 1997; Huang et al., 1998; Gronholm et al.,
1999), the low level of sequence identity between the sin were unsuccessful, so we set out to crystallize a
complex of the FERM and C-terminal tail domains. TheC-terminal domains has made it unclear whether the
merlin interaction is similar in detail to that in ERM pro- human moesin FERM (residues 1±297) and tail (residues
467±577) domains were each expressed as selenomethi-teins.
Here, we present the crystal structure of the noncova- onine (Se-Met) derivatives, and the complex was formed
in vitro and crystallized. Crystals of the complex dif-lent 1:1 complex of the recombinant FERM and tail do-
mains of human moesin. The structure reveals that the fracted X-rays to 1.9 AÊ resolution, and the structure was
solved by multiple-wavelength anomalous diffractiontail contacts the compact FERM domain as an extended
peptide inhibitor, allowing new insight into the confor- (MAD) (Table 1). In the crystal, the moesin FERM/tail
complex is present as a domain swapped dimer of com-mational events involved in ERM activation and mem-
brane±cytoskeleton crosslinking. The structure also in- plexes with residues 502±577 of the tail binding to one
FERM domain, and residues 488±494 crossing over todicates that similarities between ERM proteins and
merlin extend beyond the FERM domain and permits interact with a second FERM domain (Figure 2). Because
the protein exists in solution as a 1:1 complex, the ob-most of the oncogenic mutations of merlin to be mapped
onto this structure. Finally, the structure of moesin is a served arrangement is a crystallization artifact, and here
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Table 1. MAD Phasing and Refinement Statistics
MAD Data Collection (2.3 AÊ )
MAD Structure Factor Ratios
Wavelength (AÊ ) Completenessa (%) Rmeasa l1 l2 l3
l1 5 0.9797 89 (84) 0.065 (0.292) 0.058 0.038 0.055
(0.042)
l2 5 0.9795 89 (85) 0.067 (0.317) 0.069 0.060
(0.042)
l3 5 0.9643 89 (86) 0.068 (0.359) 0.069
(0.046)
High Resolution Data Collection and Refinement (1.9 AÊ )
Data Quality
Reflections (N) Completenessa (%) Redundancya Rmeasa
71,584 95 (92) 3.6 (3.7) 0.090 (0.445)
Refinement
Resolution range 20±1.9 AÊ
Working set
No. reflections 66,990
R 0.227
Test set
No. reflections 3568
R 0.287
Bulk solvent k 5 0.335
B 5 31.3 AÊ 2
Anisotropic overall B B11 5 23.64 AÊ 2, B22 5 21.04 AÊ 2, B33 5 4.68 AÊ 2
Model ideality
rms bonds 0.016 AÊ
rms angles 1.78
rms B, bonded atoms 4.8 AÊ 2
a Values in parentheses correspond to the highest resolution bin.
we describe the structure derived by mapping the ob- for phosphotyrosine binding (PTB), pleckstrin homology
(PH), and Enabled/VASP Homology 1 (EVH1) domainsserved interactions onto a single complex (Figure 3).
The FERM domain is composed of three structural (Forman-Kay and Pawson, 1999). These domains are
often present in cell signaling and cytoskeletal proteins,modules (F1, F2, and F3) that together form a compact
clover-shaped structure (Figure 3). F1 (residues 4±82) where they bind peptide and/or phospholipid ligands.
The unexpected presence of a PH/PTB-like domain inte-contains a 5-stranded mixed b sheet packed against an
a helix with a short 310 helix prior to the start of strand grated into the FERM domain is reminiscent of an unrec-
ognized SH2 domain that combines with other domains3. F2 (residues 96±195) is composed of five a helices,
with an excursion of 36 residues between helices B and to form an amino-terminal module of the Cbl adaptor
protein (Meng et al., 1999), and serves as a reminderC that contains a long loop and a short a helix. F3
(residues 204±297) consists of a sandwich of two orthog- that even well worked out sequence fingerprints are not
powerful enough to recognize all homologs.onal antiparallel b sheets followed by a long helix, with
a turn of 310 helix in the loop connecting the two sheets. In contrast with the expected globularity of an z80
residue domain, the C-terminal tail adopts an extended,The center of the clover is filled largely by the 13 residue
linker between F1 and F2 (which includes a short a helix) meandering structure (Figure 3) that efficiently blocks a
large area of the FERM surface. It is highly unusual forand the 8 residue linker between F2 and F3. The three-
lobed nature and secondary structure of the moesin a polypeptide this large to bind to another protein in
such an extended manner. The first ordered residuesFERM domain indicate that the structural predictions
of Turunen et al. (1998) were reasonably accurate, but (488±494) of the tail extend the second b sheet of the
F3 module by forming an antiparallel b strand alongsidecontradict the prediction made by hydrophobic cluster
analysis that the FERM domain consists of a duplication strand 5 of F3. Residues 495±501 form a poorly ordered
connection to residues 502±577 that fold into four majorof two 140 residue domains (Girault et al., 1998).
Each of the three FERM lobes is surprisingly similar a helices (designated A through D) and two short helices
that extend across the surface of domains F2 and F3.in structure to proteins whose sequences are not recog-
nizably similar to FERM domains. F1 is very similar to Because the tail domain makes few internal tertiary inter-
actions, the structure it adopts in complex with thethe structure of ubiquitin (Vijay-Kumar et al., 1987), a
fold that is found in several proteins of dissimilar se- FERM domain is unlikely to be stably adopted by an
isolated tail domain. In support of this prediction, thequence and function. F2 is similar to the structure of
acyl-CoA binding protein (Kragelund et al., 1993), which FERM domain and the FERM/tail complex are relatively
stable to proteolysis in crude bacterial extracts, whereasbinds acyl-CoAs of various acyl chain lengths. F3 shares
the fold of an adaptable ligand binding module seen the free tail is very sensitive (data not shown). In total,
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involves the binding of the C-terminal helix D of the tail
in a groove on the surface between the two sheets of
the F3 b sandwich. The side chains of Phe574 and
Met577 bind in a hydrophobic pocket formed by resi-
dues Leu216, Ile227, Lys237, Ile238, and Phe267, and
the terminal carboxylate group hydrogen bonds with
residues Asn210 and Ser214. The burial of Met577 at
the interface explains the observation that the FERM/
tail interaction is largely disrupted in ERM mutants trun-
cated at residue 575 (Gary and Bretscher, 1995; Reczek
and Bretscher, 1998). With respect to its position on F3,
this binding site is analogous to the sites of inositol
phosphate binding to PH domains (Ferguson et al., 1995;
HyvoÈ nen et al., 1995). Also, as seen in the PH domains,
a positively charged loop between strands 1 and 2 of
F3 participates in the binding. Interestingly, moesin is
the first structural example of a PH/PTB/EVH1 fold that
has a substrate (the C-terminal tail domain) bound at
both the canonical PTB and PH binding sites simultane-
ously, underscoring the flexibility of this fold as a ligand
binding module and confirming the expectation of
Forman-Kay and Pawson (1999).
In terms of electrostatics, the interface includes a re-
Figure 2. The FERM/Tail Monomer Structure Is Derived from the
gion of negative charge on the surfaces of FERM lobesDimer Seen in the Crystal
F1 and F2 that packs against an area of positive chargeResidues 495±501 adopt a poorly ordered but visible extended seg-
on the surface of the tail (Figure 5). In addition, lobe F3ment connecting the two FERM/tail complexes in the asymmetric
contains a region of positive charge noted above thatunit. However, this must be a crystallization artifact, because dy-
namic light scattering shows that the complex is monomeric in interacts with the largely neutral helix D of the tail. Aside
solution (data not shown). Also, such a dimeric arrangement is not from the FERM/tail-interface, the exposed surfaces of
possible for intact moesin, both because it exists as a monomer both the domains are dominated by regions of positive
and because the poorly ordered connecting segment is stabilized
charge (not shown).by an H bond between the C-terminal carboxylate of Pro297 with
the amide nitrogen of residue 499, and this carboxylate does not
Conformational Activationexist in full-length moesin. As indicated in the Figure by the dashed
black line, the residues 494 and 502 bound to a single FERM domain Activation of ERM proteins involves weakening the
are in close proximity (z15 AÊ ) and could easily be linked in a single FERM/tail interaction so as to unmask the membrane-
complex. Figures 2, 3A, 3B, 6, and 7 were generated with MOLSCRIPT protein and actin binding sites (Figure 1B). The remark-
(Kraulis, 1991) and Raster3D (Merritt and Bacon, 1997). able distributed nature of the tail means that its high
affinity derives from the binding affinities of the five parts
of the extended structure whose interactions are largely
the FERM/tail interactions bury a remarkable 2700 AÊ 2 of independent of each other: strand 1 and helices A, B,
the FERM surface and 2950 AÊ 2 (36%) of the tail surface. C, and D. Even if all individual affinities are moderate,
The near perfect sequence conservation among inter- the net affinity can be very high because of the chelate
face residues (Figure 4) provides a strong argument that effect (Fersht, 1999). In other words, the pieces are all
this structure represents the relevant domain complex connected to one another and the cost of losing overall
present in the dormant ERM molecules. translational and rotational entropy during binding is
only paid once. Biophysical studies of the thermody-
The FERM/Tail Interface namics and dynamics of this novel inhibitory mode will
In addition to several interaction regions of lower com- be required to provide quantitative insight into activa-
plementarity where pockets of water molecules mediate tion. However, qualitatively, one clear advantage this
the interaction, there are three regions of tight contact binding mode has over a single globular domain that
that we describe here. The first is the interaction be- binds as a unit is that, here, multiple independent signals
tween strand 1 of the tail and lobe F3, where, in addition (interactions) can contribute to achieve differing levels
to the main chain hydrogen bonding that extends the b of activation by competing with or weakening different
sheet, the side chain of Leu494 is buried in a hydropho- parts of the interaction surface.
bic pocket formed by residues Ile245, Ile248, and Phosphorylation of a specific C-terminal threonine
His288. Interestingly, the position of this tail domain contributes to the activation of ERM proteins (Matsui et
strand matches well with that observed for peptides al., 1998). In moesin, this residue, Thr558, is located on
bound to PTB domains, with the Leu494 bound in a helix C of the tail, at an edge of the interface where it
pocket equivalent to that occupied by a hydrophobic is both in contact with the FERM domain and exposed
residue found upstream of the phosphotyrosine in PTB to solvent (Figures 5 and 6). The structure shows that
substrates (Borg and Margolis, 1998). The second region phosphorylation at this position will weaken the helix
of tight contact is between the hydrophobic face of tail C/FERM interaction due to both electrostatic and steric
helix A and hydrophobic residues on helices B and D of effects. In terms of electrostatics, Thr558 is in a posi-
tively charged surface, and is positioned opposite toF2 (see Figure 4 for exact residues). The third interaction
Structure and Masking of Human Moesin
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Figure 3. The Overall Structure of the FERM/Tail Complex
(A) A stereo ribbon diagram of the complex. Visible are the three-leaf clover domain structure of the FERM domain (cyan) and the extended
conformation of the tail domain (red). Sidechains packing in this well-packed central region of the clover include Phe84, Tyr85, Pro86, Phe102,
Gln105, Val106, Ile115, Ala195, Gln196, Leu198, Tyr201, Gly202, Leu283, and Leu290.
(B) A stereo view of the complex, after rotating z908 around the horizontal axis from the view in (A), to highlight the conformation of the
C-terminal tail (red).
(C) The topologies of the three FERM lobes and the tail domain are shown schematically with helices represented by boxes and strands by
arrows. Helices shorter than six residues are considered as extended turns and are not given a letter designation. Secondary structure was
assigned using DSSP (Kabsch and Sander, 1983).
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Figure 4. Sequence Conservation for ERMs and Related Proteins
Sequences for (A) the F1, F2, and F3 lobes of the FERM domains of human moesin (Swissprot P26038), ezrin (P15311), radixin (P35241),
merlin (P35240), and band 4.1 (P11171) and (B) the C-terminal tails of human moesin, ezrin, radixin, and merlin were aligned with CLUSTALW
(Thompson et al., 1994) and manually adjusted. Secondary structure elements are indicated above the sequences and every tenth moesin
residue has a dot. Residues highlighted in cyan in the moesin sequence are involved in the FERM/tail interface (defined as residues having
Structure and Masking of Human Moesin
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Figure 5. Electrostatic Features of the FERM/Tail Interface
The molecular surfaces of the domains reveal the electrostatic potential (from negative [red] to positive [blue]) at the interface. The region
containing the C-terminal F-actin binding site is outlined, and the position of Thr558 is marked with an asterisk. Molecular surfaces in Figures
4C and 5 and the electrostatic potential were calculated using GRASP (Honig and Nicholls, 1995). The interface surfaces for residues 488±494
of the tail and their docking site are not visible.
the heart of a negatively charged surface of the FERM complex. The intimate involvement of these residues in
the FERM/tail interface provides a simple direct mecha-domain (Figure 5), where the introduction of the nega-
tively charged phosphoryl group would have a strong nism for the masking of the actin binding site. Three
arguments indicate that the structure seen here doesdetrimental effect. A mutation of Thr558 to Asp that
mimics this charge change is weakly activating (Oshiro not provide a model for the conformation that these
et al., 1998; Huang et al., 1999), indicating that the elec- residues will adopt when they bind to actin. First, phos-
trostatic change is important. In terms of sterics, the phorylation of Thr558 does not block actin binding (Mat-
side chains surrounding Thr558 approach it closely sui et al., 1998), but, as discussed above, it must cause
enough that there is not sufficient room for a phosphoryl at least some rearrangement of the tail. Second, this
group (Figure 6), so that some structural rearrangement region of the tail makes so few intramolecular tertiary
must occur, and, given the proximity of these residues interactions that its conformation is clearly heavily dic-
to the interface, any perturbations will clearly affect the tated by docking onto the FERM domain. And third, the
stability of the complex. last 26 residues of the tail is the only part of the domain
The contribution of anionic phospholipid vesicles to which has high sequence conservation of residues not
activation is less clear, but they bind to both the intact buried in the FERM/tail interface (Figure 4C). This would
dormant protein and to the isolated FERM domain of only be expected if actin binding places additional con-
ERM proteins (Niggli et al., 1995). Given the highly posi- straints on the evolution of these residues, and suggests
tively charged surface of lobe F3, we speculate that that these ªback-sideº residues are more involved in
the negatively charged phospholipids would have the actin binding than they are in the FERM/tail interaction.
highest affinity for this part of the interface, and might The observation that the FERM domain of ERM pro-
compete with and weaken the binding of helix D to the teins binds to several membrane proteins (see Figure
FERM domain. 1B) and to phospholipids has led to the expectation that
it has multiple binding sites. Although no experimental
data exist to specifically locate these binding sites onPotential Binding Sites on Activated ERM Molecules
the FERM structure, considerations of residue conser-The portion of the tail responsible for F-actin binding
vation and of homology provide guides for future studieshas been mapped to its last 34 residues (Turunen et al.,
1994), which form tail domain helices B, C, and D in the aimed at dissecting these binding functions. The first
.10 AÊ 2 more side chain surface area buried in the complex than in the isolated domains). Residues colored magenta in the merlin sequence
are those that are either invariant or conserved as hydrophobic in ERMs and merlin, and residues indicated in red below the merlin sequence
are single site missense mutations in merlin that are associated with human tumors (Turunen et al., 1998). The phosphorylation site at Thr558
is indicated with an asterisk. The six most well conserved residues among all FERM domains (Girault et al., 1999) are outlined with boxes
and highlighted in yellow. (C) Molecular surfaces, after opening the complex in Figure 3B like a book, colored to highlight those residues that
are invariant or conserved as hydrophobic in human ERMs (green and magenta surfaces), or human ERM proteins and merlin (magenta surface
only). Quantitative analysis of the enhanced conservation of the interface residues in merlin is as follows: for the FERM domain, the identity
levels among ERM proteins and merlin are 60% for interface residues versus only 36% for other surface residues; for the C-terminal tails, the
corresponding numbers are 28% versus 7%. The labeled magenta surface on the backside of the FERM domain (lobe F1) indicates sequence
conservation among ERMs and merlin in a position that is analogous to a protein binding site on the ubiquitin-like domains of Raf kinase and
elongin B (see Figure 6).
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Figure 6. Stereodiagram of the Region Surrounding Thr558
Thr558 is in van der Waals contact with FERM residues Thr235 and Pro236, and is accessible to solvent from the right between the side
chains of Arg553, Lys557, and Gln561. The electron density (from an NCS averaged map calculated with coefficients 2FO 2 2FC, aC) is
contoured at 2.2 3 rrms. A phosphoryl group modeled onto Thr558 collides with surrounding atoms from Arg553 and Gln561.
guide is the high conservation of surface residues not seen in Figure 4C, strong conservation implicates two
patches on the backside of the ERM FERM domain, ainvolved in the interface, as these residues are likely
to have a functional importance. As an example, the large one on lobe F1 and a smaller one at the edge of
lobe F2. The second guide is the similarity of lobes F1,conservation of noninterface residues in the last 26 resi-
dues of the tail discussed above would have provided F2, and especially F3 to known protein modules. The
binding sites on these analogous modules are worthan accurate indication of the location of an interaction
site even in the absence of biochemical studies. As documenting because if they represent true homologies
then positions of binding sites may be conserved de-
spite the high degree of sequence divergence. Figure 7
illustrates the five such sites that can be mapped onto
FERM domain. Among these, sites 1, 4, and 5 seem
most worthy of attention because site 1 corresponds to
the large conserved patch on domain F1 (Figure 4C),
and sites 4 and 5 are both making direct interactions
with the tail and are thus masked in the complex.
FERM/Tail Interaction in the Tumor
Suppressor Merlin
The ERM homolog merlin exists as two alternatively
spliced isoforms each containing an N-terminal domain
that shares z60% sequence identity with the FERM of
the ERMs (Rouleau et al., 1993; Trofatter et al., 1993;
Gusella et al., 1999). In contrast, the C-terminal 100
Figure 7. Potential FERM Domain Interaction Sites
amino acids of merlin isoform I have only z20% identity
The positions of five binding sites on proteins that are structurally with the ERM tail, while isoform II has a truncated C
similar to the three FERM lobes are indicated: (1) by analogy with
terminus. The present structural data reveal the en-the protein interaction site seen for elongin B (Stebbins et al., 1999)
hanced conservation of residues that lie on the moesinand the Ras binding domain of Raf kinase (Nassar et al., 1995); (2)
by analogy with the lipid binding site of the acyl CoA binding protein FERM/tail interface (Figure 4), providing strong evidence
(Kragelund et al., 1993), but this site is blocked by the loop connect- that the interaction in merlin is equivalent. A remarkable
ing the F2 helices C and D; (3) by analogy with the proline-containing 81% of the residues that are invariant between the ERM
peptide binding site on EVH1 domains (Prehoda, at al., 1999; Fed- tails and merlin lie on the interface. Interestingly, the
erov et al., 1999); (4) by analogy with the canonical peptide binding
poor sequence conservation among the last 34 residuessite of PTB domains (Zhou et al., 1996); and (5) by analogy with the
between ERMs and merlin (except for those involved ininositol phosphate binding sites on PH domains (Ferguson et al.,
1995; HyvoÈ nen et al., 1995). the interface) suggests that the FERM/tail interaction is
Structure and Masking of Human Moesin
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the only common functional constraint on this region of leading to the important conclusion that the structure
solved here is not only a model for the dormant ERMmerlin, and is consistent with the lack of a C-terminal
F-actin binding site in merlin. proteins, but a model for all FERM domains, including
those in activated ERMs.These observations confirm that the moesin structure
is a good model for merlin isoform I, providing a frame- In contrast to the residues internal to the FERM do-
main, the poor sequence conservation of residues onwork for understanding the mutations that lead to non-
functional merlin and hence tumor formation. There are the FERM/tail interface rules out this type of interaction
in other FERM domain±containing proteins. However,14 single site substitution mutations that are associated
with human tumors (Figure 4) (Turunen et al., 1998). Six the binding sites of other FERM domains may also be
regulated by peptide inhibitors, albeit through a set ofof these residues are buried in FERM domain, where
they are likely to cause destabilization or misfolding. different specific interactions. Indeed, the highly effi-
cient and versatile inhibition mode revealed here pro-Interestingly, these buried mutations are at positions
throughout the FERM domain (three in F1, one in F2, vides a paradigm for thinking of other cytoskeletal pro-
teins that are regulated by masking. Furthermore, theone in the linker between F2 and F3, and one in F3),
indicating that the whole FERM unit is important for structure of the moesin FERM/tail complex presented
here opens the door for refined mutagenesis experi-merlin function. Of the eight other mutations, three (mer-
lin Leu535Pro, Gln538Pro, and Leu539His) correspond ments aimed at elucidating details of the structure±
function relations of ERM proteins, merlin, and all FERMto tail residues in moesin (Val518, His521, and Leu522)
that are on the interface, at the site of tight association domains.
with lobe F2. The remaining five surface mutations are
scattered over the FERM domain (two in F1, one in the Experimental Procedures
linker between F1 and F2, one in F2, and one in F3) and
Protein Expression and Purificationdo not cluster into a region on the surface. In addition
The cDNA sequences encoding the human moesin FERM (residuesto these natural mutations, mutagenesis experiments in
1±296) tail (residues 467±577) domains were amplified by PCR from
Drosophila have been used to identify important func- clone HEBA06 (a generous gift from Dr. Stachowitz, Genzentrum,
tional regions of merlin, including the ªblue boxº region Munich, Germany) for expression in a pQE vector (Qiagen). All re-
that includes residues corresponding to 161±167 of the combinant sequences were determined to be free of PCR errors.
For the expression of Se-Met substituted protein, each moesin con-moesin FERM domain (LaJeunesse et al., 1998). A mis-
struct was cotransformed with the pRep4 repressor plasmid (Qia-sense mutation (Met177Ile in Drosophila merlin) corre-
gen) into the methionine auxotrophic E. coli strain B834(DE3) (Nova-sponding to Gln167 in moesin resulted in merlin with
gen). Frozen cells from 1 L and 3 L cultures expressing FERM and
lowered activity, similar to that of an isolated merlin tail domains, respectively, were thawed and resuspended together.
FERM domain. While moesin Gln167 is not on the FERM/ Cell lysis and purification of the complex were carried out by essen-
tail interface, the neighboring residues 161±163 are, sug- tially the same protocol as was used for the isolated FERM domain
(Reczek et al., 1997). 1±2 mM DTT was added to all buffers to protectgesting that the blue box mutation might lead to weaken-
the Se-Met from oxidation.ing of the complex. In contrast to the missense mutation,
deletion of residues in the blue box lead to nonfunctional
Structure Determinationmerlin, which again indicates the importance of proper
Crystals were grown at 48C using the hanging drop vapor diffusion
folding of the FERM domain. method with drops containing 8 ml of protein solution at a concentra-
tion of 5 mg ml21 in 10 mM HEPES (pH 7.5), 20 mM NaCl, 1 mM
EDTA, and 5 mM DTT and 4 ml of reservoir solution consisting ofThe FERM Domain of Other Members of the Band
100 mM HEPES (pH 7.8), 100±150 mM Li2SO4, and 18%±20% PEG-4.1 Superfamily
3350. For data collection, crystals were transferred directly fromSequence conservation indicates that the structure of
drops to a cryobuffer consisting of the reservoir solution supple-
moesin is a useful prototype for the FERM domains of mented with 10% glycerol. After a few minutes, they were flash
other proteins. In fact, the six best conserved FERM frozen in an N2 stream.
MAD data were collected at the Cornell High Energy Synchrotronresidues (Figure 4) (Girault et al., 1999) are buried in the
Source (CHESS) beamline F2 using an ADSC CCD detector andstructure, consistent with the conservation of the fold
processed with MOSFLM (Leslie, 1993) and SCALA (Collaborativethroughout the band 4.1 superfamily. Although there are
Computational Project, Number 4, 1994). The space group was origi-three structural domains (lobes F1, F2, and F3) making
nally designated as P2221 with unit cell indices: a 5 54 AÊ , b 5up the FERM domain, two observations suggest that 112 AÊ , and c 5 153 AÊ . Normal structure factors for the anomalous
the FERM domain functions as a single unit rather than scatterers were calculated by MADSYS (Hendrickson and Ogata,
1997), and Patterson correlation analysis using SHELX (Sheldricka collection of three separate modules. First, the linkers
et al., 1993) identified eight selenium positions that were used forbetween the three lobes are rather short (13 and 8 resi-
protein phase calculation with MADSYS. The overall figure of meritdues), and their sequences are well-conserved in the
was 0.444 to 2.5 AÊ resolution. The resulting electron density mapERM proteins, merlin, and band 4.1 (Figure 4). Second,
showed a clear protein±solvent boundary for two FERM/tail com-
interacting side chains in this central region, including plexes in the asymmetric unit. After solvent flattening using PHASES
those from the linkers and the domains, are very well (Furey and Swaminathan, 1997), one complex had much stronger
electron density and its Ca backbone was modeled. The main chainconserved, and two of the aforementioned six highly
atoms were then built automatically using O (Jones et al., 1991).conserved FERM residues, Gln105 and Gly202, are in
Modeling of side chains and subsequent rounds of manual fittingthis core. Such interdomain interactions indicate that
were carried out using CHAIN (Sack and Quiocho, 1997) and refine-structural changes in one domain would impact and
ments were done in X-PLOR (BruÈ nger, 1996). The eight selenium
possibly destabilize the other domains. This conserved positions found during phasing all corresponded to methionines in
central core of residues provides evidence that the this first complex. The electron density for the second molecule,
which was related to the first by a pseudo 2-fold axis parallel to c,FERM domain remains structurally rigid upon activation,
Cell
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was initially difficult to interpret. After several rounds of fitting and Bretscher, A. (1999). Regulation of cortical structure by the ezrin-
radixin-moesin protein family. Curr. Opin. Cell Biol. 11, 109±116.simulated annealing refinements, difference Fourier maps revealed
peaks that represented 16 selenium positions for the second mole- BruÈ nger, A.T. (1996). X-PLOR Version 3.8, Department of Molecular
cule in an orientation that suggested two overlapping half-occupied Biophysics and Biochemistry, Yale University, New Haven, CT.
complexes separated by 5 AÊ in a direction perpendicular to the c Chishti, A.H., Kim, A.C., Marfatia, S.M., Lutchman, M., Hanspal M.,
axis. These ghost images led us to suspect that the space group Jindal, H., Liu, S.C., Low, P.S., Rouleau, G.A., Mohandas, N., et al.
was misassigned, with a pseudo 21-screw axis being assigned as (1998). The FERM domain: a unique module involved in the linkage
crystallographic and a crystallographic 2-fold axis being assigned of cytoplasmic proteins to membrane. Trends Biochem. Sci. 23,
as pseudo. This problem was corrected by changing the space 281±282.
group from P2221 to the nonstandard P2212. After the unit cell axes Collaborative Computational Project, No. 4. (1994). The CCP4 suite:were permuted to convert the diffraction data and the model to
programs for protein crystallography. Acta Crystallogr. 50, 760±763.the standard P2221 (with unit cell indices: a 5 54 AÊ , b 5 153 AÊ ,
Doi, Y., Itoh, M., Yonemura, S., Ishihara, S., Takano, H., Noda, T.,c 5112 AÊ ), the electron density for the second complex immediately
and Tsukita, S. (1999). Normal development of mice and unimpairedimproved. After this problem was resolved, crystallographic refine-
cell adhesion/cell motility/actin-based cytskeleton without compen-ment was continued against a more complete 1.9 AÊ resolution data
satory up-regulation of ezrin or radixin in moesin gene knockout. J.set collected from two crystals at CHESS beamlines F1 and F2.
Biol. Chem. 274, 2315±2321.Refinement included tight noncrystallographic symmetry restraints
Dransfield, D.T., Bradford, A.J., Smith, J., Martin, M., Roy, C.,on Ca positions.
Mangeat, P.H., and Goldenring, J.R. (1997). Ezrin is a cyclic AMP-There are two FERM/tail complexes in the asymmetric unit, with
dependent protein kinase anchoring protein. EMBO J. 16, 35±43.a root-mean-square (rms) deviation of 0.05 AÊ for Ca positions. The
current model includes residues 4±297 and 488±577 for each com- Fedorov, A.A., Federov, E., Gertler, F., and Almo, S.C. (1999). Struc-
plex, as well as 412 water molecules and 2 sulfate ions. Unusual ture of EVH1, a novel proline-rich ligand-binding module involved
geometries in well-ordered regions of the structure include a cis- in cytoskeletal dynamics and neural function. Nat. Struct. Biol. 6,
Pro at residue 75 and main chain dihedrals of ` 5 668, c 5 21048 661±666.
at Asp252. Mobile segments whose conformational details are less Fersht, A. (1999). Structure and Mechanism in Protein Science: A
reliable are residues 21±23, 260±263, and 495±501. Due to weak Guide to Enzyme Catalysis and Protein Folding (New York: W. H.
electron density, the following surface residues are modeled as Ala Freeman and Co.), pp. 345±346.
in both complexes: Lys64, Asp69, Lys72, Lys139, Arg495, Asp497,
Ferguson, K.M., Lemmon, M.A., Schlessinger, J., and Sigler, P.B.
Met499, Glu516, and Lys517.
(1995). Structure of the high affinity complex of inositol trisphos-
phate with a phospholipase C pleckstrin homology domain. Cell 83,
Structure Analysis 1037±1046.
Structural similarities were determined using DALI (Holm and
Forman-Kay, J.D., and Pawson, T. (1999). Diversity in protein recog-Sander, 1993). Lobe F1 was most similar to the structure of ubiquitin
nition by PTB domains. Curr. Opin. Struct. Biol. 9, 690±695.(Vijay-Kumar et al., 1987) (PDB code 1UBI; rms deviation of 1.7 AÊ
Funayama, N., Nagafuchi, A., Sato, N., Tsukita, S., and Tsukita, S.between 70 Ca positions and Z score 5 10.2). Lobe F2 was most
(1991). Radixin is a novel member of the band 4.1 family. J. Cellsimilar to the acyl-CoA binding protein (Kragelund et al., 1993) (PDB
Biol. 115, 1039±1048.code 1ACA; rms deviation of 2.7 AÊ for 74 Ca atoms and Z score 5
7.6). Lobe F3 was most similar to the phosphotyrosine binding do- Furey, W., and Swaminathan, S. (1997). PHASES-95: a program
main of insulin receptor substrate 1 (Zhou et al., 1996) (PDB code package for processing and analyzing diffraction data from macro-
1IRS; rms deviation of 2.2 AÊ for 91 Ca atoms and Z score 5 12.1). molecules. Methods Enzymol. 277, 590±620.
Accessible surface areas were calculated using the program Gary, R., and Bretscher, A. (1995). Ezrin self-association involves
AREAIMOL (Collaborative Computational Project, No. 4, 1994). binding of an N-terminal domain to a normally masked C-terminal
domain that includes the F-actin binding site. Mol. Biol. Cell 6, 1061±
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